Auteurs
Merge
Accueil
Racine
Merge
Exploration
Accueil
Racine
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Merge (Accueil)

Index « Auteurs » - entrée « H. Kuwabara »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
H. Kurtel < H. Kuwabara < H. Kuçukoglu  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
003895 (2000) O G Rousset [Canada] ; P. Deep ; H. Kuwabara ; A C Evans ; A H Gjedde ; P. CummingEffect of partial volume correction on estimates of the influx and cerebral metabolism of 6-[(18)F]fluoro-L-dopa studied with PET in normal control and Parkinson's disease subjects.
004616 (1995) H. Kuwabara [Canada] ; P. Cumming ; Y. Yasuhara ; G C Léger ; M. Guttman ; M. Diksic ; A C Evans ; A. GjeddeRegional striatal DOPA transport and decarboxylase activity in Parkinson's disease.
004809 (1995) H. Kuwabara [Canada] ; P. Cumming ; Y. Yasuhara ; G. C. Leger ; M. Guttman ; M. Diksic ; A. C. Evans ; A. GjeddeRegional striatal DOPA transport and decarboxylase activity in Parkinson's disease
004A85 (1993) A. Gjedde [Canada] ; G C Léger ; P. Cumming ; Y. Yasuhara ; A C Evans ; M. Guttman ; H. KuwabaraStriatal L-dopa decarboxylase activity in Parkinson's disease in vivo: implications for the regulation of dopamine synthesis.
004A91 (1993) P. Cumming [Canada] ; G C Léger ; H. Kuwabara ; A. GjeddePharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
004B20 (1993) H. Hoshi [Canada] ; H. Kuwabara ; G. Léger ; P. Cumming ; M. Guttman ; A. Gjedde6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods.
004C33 (1993) M. Guttman [Canada] ; G. Léger [Canada] ; A. Reches [Israël] ; A. Evans [Canada] ; H. Kuwabara [Canada] ; J. M. Cedarbaum [États-Unis] ; J. M. Gjedde [Canada]Administration of the new COMT inhibitor OR‐611 increases striatal uptake of fluorodopa
004C38 (1993) A. Gjedde [Canada] ; G. C. Leger ; P. Cumming ; Y. Yasuhara ; A. C. Evans ; M. Guttman ; H. KuwabaraStriatal L-DOPA decarboxylase activity in Parkinson's disease in vivo : implications for the regulation of dopamine synthesis
004C73 (1993) M. Guttman [Canada] ; G. Leger ; A. Reches ; A. Evans ; H. Kuwabara ; J. M. Cedarbaum ; A. GjeddeAdministration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa
004C76 (1993) H. Hoshi [Canada] ; H. Kuwabara ; G. Leger ; P. Cumming ; M. Guttman ; A. Gjedde6-[18F]fluoro-L-DOPA metabolism in living human brain : a comparison of six analytical methods

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Merge

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i -k "H. Kuwabara" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i  \
                -Sk "H. Kuwabara" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    Author.i
   |clé=    H. Kuwabara
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022